Practical Applications from What We Heard at Virtual ACR

Listen to experts report on current publications, posters, and sessions from a recent rheumatology conference. Faculty discuss the latest on Systemic sclerosis ILD and Progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib

Launched: November 13, 2020

Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis

Launched: November 13, 2020

Efficacy of Mycophenolate Mofetil (MMF) in African Americans vs Non-African Americans with SSc-ILD

Launched: November 13, 2020

What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD

Launched: November 13, 2020

Machine Learning Assisted Prediction of Progression in SSc-ILD-

Launched: November 13, 2020

Factors Associated with Disease Progression in the SENSCIS Trial

Launched: November 13, 2020

Biochemical Profiles of Radiographic Patterns in SSc-ILD

Launched: November 13, 2020